Home / Diabetes In Control (page 532)

Diabetes In Control

Avandia, Actos May Raise Risk of Macular Edema

Pioglitazone (Actos) and rosiglitazone (Avandia) appear to substantially boost risk of macular edema in type 2 diabetes, an observational study found. Incidence of diabetic macular edema was 1.3% at 1 year on a thiazolidinedione (TZD) compared with just 0.2% among type 2 diabetes patients not on one of those agents. …

Read More »

Fish Oil Fails to Reduce CV Event Risk

Omega-3 fatty acids did not reduce the rate of cardiovascular events in high-risk patients with prediabetes or diabetes followed for half a dozen years, the randomized ORIGIN trial found. Cardiovascular deaths occurred among 9.1% and 9.3% of those randomized to n-3 fatty acids or placebo, respectively. N Engl J Med 2012 

Read More »

Statins Sap Energy

Statin drugs may leave users — especially women — feeling drained and tired on exertion, a clinical trial suggested. Combined scores for change in energy and exertional fatigue worsened after starting a statin compared with placebo (P=0.005). For women, scores suggested that as many as 40% felt more tired and …

Read More »